NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
March 20, 2026 — Co-Diagnostics expands CoSara joint venture across South Asia, targeting $13B market with PCR Pro® and SARAGENE® diagnostics platforms in Bangladesh, Pakistan, Nepal, Sri Lanka.
March 20, 2026 — Study finds teens who replace 30 minutes of sedentary time with physical activity reduce insulin resistance by 15%, lowering Type 2 diabetes risk. Research presented at American Heart Association conference.
March 20, 2026 — Co-Diagnostics' joint venture expands into Bangladesh, Pakistan, Nepal & Sri Lanka, targeting a $13B market for its PCR Pro point-of-care platform & SARAGENE diagnostics.
March 20, 2026 — Study of 300,000 adults finds elevated blood pressure in 30s-40s increases heart and kidney disease risk after 40. Early monitoring crucial for long-term health.
March 20, 2026 — Soligenix receives UK Promising Innovative Medicine designation for SGX945 to treat Behçet's disease, strengthening rare disease pipeline with regulatory recognition from MHRA.
March 20, 2026 — Calidi Biotherapeutics advances oncolytic virus therapy, a new cancer treatment using viruses to destroy tumors. BioMedWire reports on this transformative biomedical innovation.
March 20, 2026 — LIXTE Biotechnology's LB-100 compound may enhance cancer treatment effectiveness by increasing tumor sensitivity to chemotherapy/radiation and boosting immune response. Learn about this promising oncology development.
March 20, 2026 — Black Hawk Acquisition's target, Vesicor Therapeutics, appoints Dr. Michael Tolentino as CEO to lead its p53-based cancer drug platform toward FDA trials and a SPAC merger.
March 20, 2026 — Catalyst Crew Technologies submits to FINRA to change name to LataMed AI Corp., reflecting its shift to AI healthcare tech focused on Latin America, with no change to capital structure.
March 19, 2026 — MEDICLIN AG invites stakeholders to its 2026 virtual press conference on March 27 to discuss 2025 financial results, outlook, and developments in German healthcare.
March 19, 2026 — Soligenix's HyBryte™ for cutaneous T-cell lymphoma gains peer-reviewed support in Expert Opinion on Investigational Drugs, highlighting safety and efficacy ahead of Phase 3 trial analysis in 2026.
March 19, 2026 — Davis & Goldberg Orthodontics offers premier braces and Invisalign treatments in Greensboro, NC. Their advanced technology and personalized care help patients achieve confident, healthy smiles.
March 19, 2026 — Seacoast Braces in Dover, NH offers personalized sleep apnea treatment with oral appliances and advanced care. Learn how their holistic approach improves sleep and health for local residents.
March 19, 2026 — New research shows pregnant women can reduce hypertension risk by 30% with less sitting and more light activity. Study presented at American Heart Association meeting offers practical pregnancy health guidance.
March 19, 2026 — Aditxt appoints Jeff Busch as CEO of Ignite Proteomics to lead commercial expansion of precision oncology platform using functional protein profiling to guide cancer therapy selection.
March 19, 2026 — Annovis Bio partners with NeuroRPM to implement AI-powered monitoring in Parkinson's disease trials, using wearable tech to track symptoms and enhance evaluation of buntanetap treatment.
March 19, 2026 — Soligenix announces HyBryte clinical summary published, highlighting safety and efficacy for cutaneous T-cell lymphoma. Phase 3 trial advances with 2026 analysis expected.
March 19, 2026 — Aclarion adopts a one-year stockholder rights plan to protect against hostile takeovers, ensuring fair value for investors and stability for its Nociscan healthcare technology platform.
March 19, 2026 — Soligenix CEO discusses promising Phase 3 data for HyBryte™ in cutaneous T-cell lymphoma, highlighting strong response rates and upcoming milestones in BioMedWire feature.
March 19, 2026 — Aclarion updates on Nociscan platform for chronic back pain, targeting 2026 clinical trial results & US insurance reimbursement to expand adoption of its AI-driven diagnostic technology.